|
|
News for Healthier Living
Blood Test Predicts Immunotherapy Benefit Early Among Patients With Advanced Lung Cancer
Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy -- a blood test that detects circulating tumor DNA (ctDNA) -- can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.
August 3, 2026
August 4 2026August 3 2026August 1 2026July 31 2026July 30 2026July 29 2026July 28 2026July 27 2026July 26 2026July 25 2026July 24 2026July 23 2026July 22 2026July 21 2026
|
|
|
|
|